Defunct Company
Total Trials
4
As Lead Sponsor
As Collaborator
0
Total Enrollment
1,024
NCT00640848
Almorexant in Primary Insomnia
Phase: Phase 1
Role: Lead Sponsor
Start: May 31, 2006
Completion: Sep 30, 2007
NCT00606593
Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia
Phase: Phase 2
Start: Dec 31, 2007
Completion: May 31, 2008
NCT00608985
Almorexant (ACT 078573) in Adult Subjects With Chronic Primary Insomnia
Phase: Phase 3
Start: Mar 31, 2008
Completion: Nov 30, 2009
NCT01987739
Study to Evaluate the Relative Abuse Potential of Almorexant in Recreational Drug Users
Start: Sep 30, 2009
Completion: Feb 28, 2010